You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,236,328


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,236,328
Title:Euglobulin-based method for determining the biological activity of defibrotide
Abstract: It is disclosed a method for determining the biological activity of defibrotide, which comprises the steps of: a) bringing into contact defibrotide, mammalian euglobulin and a substrate specific for the plasmin which, by reaction with the plasmin, provides a measurable product; and b) measuring the amount of product formed at successive times, to thereby determine the biological activity of the defibrotide. Liquid defibrotide formulations are also disclosed, preferably water solutions, having a defined biological activity and, in particular, having an activity of 25 to 35 IU/mg of defibrotide, preferably from 27 to 32 IU/mg and, more preferably, from 28 to 32 IU/mg.
Inventor(s): Ignoni; Terenzio (Solbiate, IT), Kumar; Vijay (Casnate, IT), Islam; Khalid (Massagno, IT)
Assignee: GENTIUM S.R.L. (Villa Guardia, IT)
Application Number:17/459,169
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,236,328

Introduction

Patent analysis is a crucial step in understanding the intellectual property landscape, particularly for businesses and inventors looking to protect and leverage their innovations. This article will delve into the specifics of United States Patent 11,236,328, focusing on its scope, claims, and the broader patent landscape it operates within.

Understanding Patent Scope and Claims

Before diving into the specifics of US Patent 11,236,328, it is essential to understand what constitutes the scope and claims of a patent.

  • Patent Scope: This refers to the breadth and depth of protection afforded by a patent. It is often measured using metrics such as independent claim length and independent claim count, which can indicate the complexity and breadth of the patent[3].
  • Patent Claims: These are the most critical part of a patent application, defining the boundaries of what is protected. Claims must be clear, concise, and specific to ensure that the invention is adequately protected[5].

Overview of US Patent 11,236,328

US Patent 11,236,328, titled "Euglobulin-based method for determining the presence of a fibrinolytic inhibitor," involves a method related to medical diagnostics.

Invention Description

This patent describes a method for determining the presence of a fibrinolytic inhibitor, which is crucial in medical diagnostics, particularly in assessing conditions related to blood clotting and fibrinolysis. The method involves using euglobulin, a fraction of blood plasma, to evaluate the activity of fibrinolytic inhibitors.

Claims Analysis

The claims section of the patent is where the inventors define exactly what is protected. Here are some key points:

  • Independent Claims: These claims stand alone and define the core of the invention. For US Patent 11,236,328, the independent claims would outline the specific steps and components involved in the euglobulin-based method.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or variations of the invention. They are narrower in scope but still crucial for comprehensive protection.

Patent Landscape and Technology Area

To understand the broader context of US Patent 11,236,328, it is important to look at the patent landscape within its technology area.

Technology Area Classification

Patents are classified into specific technology areas to facilitate analysis and comparison. The USPTO uses the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields. US Patent 11,236,328 would fall under the category related to medical diagnostics or biochemistry[1].

Trends in Patenting

The number of patents in the medical diagnostics and biochemistry fields has been increasing, reflecting the growing importance of these areas in healthcare and research. High R&D industries, such as pharmaceuticals and biotechnology, often have high rates of patenting in these fields[1].

Patent Scope Metrics

To assess the scope of US Patent 11,236,328, metrics such as independent claim length and independent claim count can be used.

  • Independent Claim Length: Longer independent claims often indicate a narrower but more specific scope, which can be beneficial for avoiding litigation and ensuring clarity[3].
  • Independent Claim Count: A higher number of independent claims can suggest a broader scope, covering multiple aspects of the invention[3].

Commercial and Practical Implications

Understanding the scope and claims of a patent like US 11,236,328 is crucial for commercial and practical purposes.

Commercial Potential

The commercial potential of a patent is closely tied to its scope and the clarity of its claims. A well-defined scope can attract licensing partners and investors, while ambiguous claims can lead to litigation and reduced commercial value[5].

Costs and Process

The process of obtaining and maintaining a patent is costly and time-consuming. For US Patent 11,236,328, the costs would include drafting and filing the application, patent prosecution, and maintenance fees over the patent's lifetime. These costs can range from $30,000 to significantly more, especially for international patents[5].

Determining Inventorship

Correctly determining who should be listed as an inventor is critical for the validity of the patent.

  • Conception and Reduction to Practice: In the U.S., inventorship involves the conception of the idea and the reduction of that idea to practice. This two-step process ensures that only those who have contributed to the invention are listed as inventors[2].

Conclusion

US Patent 11,236,328 represents a specific innovation within the broader landscape of medical diagnostics and biochemistry. Understanding its scope, claims, and the broader patent landscape is essential for inventors, businesses, and researchers looking to navigate the complex world of intellectual property.

Key Takeaways

  • Patent Scope and Claims: These define the boundaries of what is protected and are critical for the commercial and practical value of a patent.
  • Technology Area Classification: Patents are classified into specific areas to facilitate analysis and comparison.
  • Commercial Potential: A well-defined scope and clear claims are essential for attracting licensing partners and investors.
  • Costs and Process: Obtaining and maintaining a patent is costly and time-consuming.
  • Determining Inventorship: Correctly identifying inventors is crucial for the validity of the patent.

FAQs

  1. What is the primary purpose of patent claims in a patent application?

    • The primary purpose of patent claims is to define the boundaries of what is protected by the patent, ensuring that the invention is clearly and specifically described.
  2. How are patents classified into technology areas?

    • Patents are classified using the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields. This helps in analyzing trends and comparing patents within specific areas[1].
  3. What metrics can be used to measure the scope of a patent?

    • Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent, indicating its breadth and clarity[3].
  4. Why is determining inventorship important in patent law?

    • Determining inventorship is crucial because it ensures that only those who have contributed to the conception and reduction to practice of the invention are listed as inventors, which affects the validity of the patent[2].
  5. What are the typical costs associated with obtaining and maintaining a U.S. patent?

    • The costs can range from $8,000 to $20,000 for drafting and filing a non-provisional patent application, with additional costs for patent prosecution and maintenance, totaling around $30,000 or more over the patent's lifetime[5].

Sources

  1. National Science Foundation. Invention: U.S. and Comparative Global Trends. January 15, 2020.
  2. Oregon State University. Determining Inventorship for US Patent Applications.
  3. SSRN. Patent Claims and Patent Scope. September 29, 2016.
  4. Google Patents. US11236328B2 - Euglobulin-based method for determining the presence of a fibrinolytic inhibitor.
  5. University of Kansas. Intellectual Property Protection.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,236,328

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Jazz Pharms Inc DEFITELIO defibrotide sodium SOLUTION;INTRAVENOUS 208114-001 Mar 30, 2016 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF ADULT AND PEDIATRIC PATIENTS WITH HEPATIC VENO-OCCLUSIVE DISEASE (VOD), ALSO KNOWN AS SINUSOIDAL OBSTRUCTION SYNDROME (SOS), WITH RENAL OR PULMONARY DYSFUNCTION FOLLOWING HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,236,328

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2012383169 ⤷  Subscribe
Brazil 112014031934 ⤷  Subscribe
Canada 2874960 ⤷  Subscribe
China 104619857 ⤷  Subscribe
China 110079580 ⤷  Subscribe
Denmark 2864496 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.